JNJ post-Kenvue separation is a focused pharma and medtech business. Innovative Medicines portfolio offsetting Stelara biosimilar erosion with Tremfya, Carvykti, Darzalex. MedTech accelerating on Abiomed and Shockwave acquisitions. Talc litigation continues to overhang valuation despite multiple settlement attempts.
Thesis reviewed May 29, 2026
Johnson & Johnson is headquartered in United States, which is currently showing elevated risk signals.
🇺🇸United States82EXITView United States risk detail →💊Pharma0NEUTRAL| Ticker | Company | Score | Gap | Signal Δ | Action |
|---|---|---|---|---|---|
| AZN | AstraZeneca PLC | 50 | +11% | ↓0% | EARLY |
| JNJ | Johnson & Johnson | 50 | +8% | ↓0% | NEUTRAL |
| REGN | Regeneron Pharmaceuticals Inc. | 50 | -16% | ↓0% | AVOID |
| TAK | Takeda Pharmaceutical Company Limited | 50 | +10% | ↓0% | NEUTRAL |
| LLY | Eli Lilly and Company | 50 | +24% | ↓0% | EARLY |
| PFE | Pfizer Inc. | 50 | +6% | ↓0% | NEUTRAL |
| NVO | Novo Nordisk A/S | 50 | +15% | ↓0% | EARLY |
Investors who hold JNJ may also have indirect exposure through these country funds.
Carvykti CAR-T sales beat expectations
Talc bankruptcy settlement strategy update
Estimates · Yahoo Finance · Not audited figures
| Politician | Party | Type | Amount | Trade Date | Return |
|---|---|---|---|---|---|
| John Boozman | Sell | $1k–$15k | Aug 20, 26 | ||
| Richard Dean Dr McCormickGA | Buy | $1k–$15k | Jul 30, 26 | ||
| Alan Armstrong | Buy | $15k–$50k | Mar 27, 26 | ||
| Alan Armstrong | Buy | $1k–$15k | Mar 30, 26 | ||
| Thomas H. KeanNJ | Sell | $1k–$15k | Jun 29, 26 | ||
| Thomas H. KeanNJ | Sell | $1k–$15k | Jun 2, 26 | ||
| Lloyd DoggettTX | Buy | $1k–$15k | Jun 9, 26 | ||
| John Boozman | Sell | $1k–$15k | Mar 19, 26 | -5.6% | |
| Thomas H. KeanNJ | R | Sell | $1k–$15k | Mar 26, 26 | -4.8% |
| Richard Dean Dr McCormickGA | R | Sell | $1k–$15k | Mar 19, 26 | -4.9% |
| Lloyd DoggettTX | D | Buy | $1k–$15k | Mar 10, 26 | -6.0% |
| Thomas H. KeanNJ | R | Sell | Unknown amount | Jan 23, 26 | -7.7% |
| Julie JohnsonTX | D | Buy | $1k–$15k | Dec 18, 25 | +3.8% |
| Lloyd DoggettTX | D | Buy | $1k–$15k | Dec 9, 25 | +9.9% |
| Marjorie Taylor Mrs GreeneGA | R | Buy | $1k–$15k | Dec 24, 24 | +61.9% |
| Jared MoskowitzFL | D | Buy | $1k–$15k | Nov 8, 24 | +57.0% |
| Josh GottheimerNJ | D | Buy | $1k–$15k | Nov 26, 24 | +57.0% |
| Josh GottheimerNJ | D | Buy | $1k–$15k | Nov 22, 24 | +57.0% |
| Marjorie Taylor Mrs GreeneGA | R | Buy | $1k–$15k | Nov 25, 24 | +51.1% |
| Thomas H Tuberville | Sell | $15k–$50k | Oct 29, 24 | +53.7% |